Search Thermo Fisher Scientific
Guide clinical decision making with molecular diagnostics
Working together with laboratories, Thermo Fisher Scientific played a critical role in helping to solve the world’s greatest challenges during the COVID‑19 pandemic. As a leader in the industry, we will continue to be here for you—delivering trusted molecular diagnostic solutions that help you guide effective patient outcomes.
Laboratories around the world invested billions in resources to support molecular testing for SARS-CoV-2, but the value of these tests will make a significant impact on global health beyond the pandemic. Molecular testing enables accurate and actionable results that can enhance the quality of patient care and shape the future for healthcare best practices.
While traditional methods, such as culture, continue to have an important role in diagnosis of infectious diseases, rapid PCR technology has clinical evidence to support improved patient outcomes. The technology is substantial, running thousands of highly sensitive samples with same day results.
Explore the resources below to learn more about the role molecular testing can serve in patient management and care decisions.
Molecular syndromic panels for infectious disease testing
This article summarizes highlights learned from syndromic panels for Respiratory Tract Infections (RTIs), Gastrointestinal (GI) Infections, Urinary Tract Infections (UTIs), Vaginal and Sexually Transmitted Infections (STIs), and Antimicrobial Resistance (AMR) markers.
Educational resources by disease area
Respiratory tract infections
Molecular testing has improved diagnosis of circulating respiratory viruses and atypical bacteria.
Learn more ›
Urinary tract infections
Discover how to use PCR for the detection of urinary tract infections and the growing evidence for this novel testing method.
Read blog › | 7 min read
Request infographic ›
Watch webinar ›
Gastrointestinal tract infections
There are challenges in diagnosing infectious gastroenteritis. Molecular testing can enable laboratories to address those challenges.
Women’s health
From the detection of STIs to both commensal and pathogenic microbes, PCR delivers quick results from a single sample.
Watch webinar › | 76 min watch
Antibiotic resistance
Next step for Molecular Diagnostics and Antimicrobial Resistance: How to Maximize Advanced Technology in the Lab.
Watch webinar › | 60 min watch
Learning guides
Respiratory Tract Infections Learning Guide
This comprehensive review of viral, bacterial, fungal, and parasitic RTIs is divided into four chapters.
HIV Learning Guide: A Primer for Healthcare Professionals
This comprehensive HIV learning guide is offered with case studies in four modules and is edited by HIV healthcare experts from Senegal, Nigeria, India, and Brazil.
Blogs, articles, and white papers
Simplify diagnostic test implementation in clinical labs
Educational resources on implementing diagnostic tests
Leveraging Syndromic Testing to Improve Patient Care
An interview with Jennifer Dien Bard, PhD
The Challenges Posed by Overutilization of Antibiotics
Health organizations have identified the growing rate of antimicrobial resistance as a global and public health concern.
Read blog | 9 min read
Is it Time to Substitute Culture With Molecular Diagnostics?
Read why laboratories newly equipped with MDx infrastructure may be in an advantageous position to expand testing menus to include infectious diseases beyond SARS-CoV-2.
SARS-CoV-2: Mutation testing & variant surveillance
Learn how PCR genotyping can support early detection of new variants and quickly confirm viral mutation.
Style Sheet for Global Design System